Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
MARKETS
3 Stocks Boosting The Health Care Sector Higher
By TheStreet Wire
Aug 21, 2015 4:34 PM EDT
PRESS RELEASES
Cellectar To Present At BIO CEO & Investor Digital Conference
By GlobeNewswire
Feb 10, 2021 8:30 AM EST
PRESS RELEASES
Cellectar Receives Orphan Drug Designation From The European Commission For CLR 131 In Waldenstrom's Macroglobulinemia
By GlobeNewswire
Jan 27, 2021 8:30 AM EST
PRESS RELEASES
Cellectar Initiates Pivotal Trial Of CLR 131 In Waldenstrom's Macroglobulinemia
By GlobeNewswire
Jan 12, 2021 8:30 AM EST
PRESS RELEASES
Cellectar Biosciences Announces Closing Of $24.5 Million Underwritten Public Offering And $20.5 Million Concurrent Private Placement
By GlobeNewswire
Dec 28, 2020 4:05 PM EST
PRESS RELEASES
Cellectar Biosciences Announces Pricing Of $24.5 Million Underwritten Public Offering And $20.5 Million Concurrent Private Placement
By GlobeNewswire
Dec 23, 2020 8:38 AM EST
PRESS RELEASES
Cellectar Biosciences Announces Proposed Underwritten Public Offering And Concurrent Private Placement
By GlobeNewswire
Dec 22, 2020 5:27 PM EST
PRESS RELEASES
Cellectar Biosciences' CLR 131 Demonstrates Preliminary Activity In Phase I Study For Pediatric Brain And Solid Tumors
By GlobeNewswire
Nov 5, 2020 9:00 AM EST
PRESS RELEASES
Cellectar Reports Data On CLR 131 Phase 2 CLOVER-1 Study In Triple Class Refractory Multiple Myeloma Patients
By GlobeNewswire
Sep 9, 2020 8:00 AM EDT
PRESS RELEASES
Cellectar Presents Poster At The AACR VIRTUAL MEETING: ADVANCES IN MALIGNANT LYMPHOMA
By GlobeNewswire
Aug 17, 2020 10:01 AM EDT
PRESS RELEASES
Cellectar Announces Poster Presentation At The International Symposium On Pediatric Neuro-Oncology (ISPNO) Annual Meeting
By GlobeNewswire
Aug 4, 2020 8:00 AM EDT
PRESS RELEASES
Cellectar Appoints Dr. John Friend As Chief Medical Officer
By GlobeNewswire
Jul 1, 2020 8:00 AM EDT
PRESS RELEASES
Cellectar To Be Granted EU Patent For Phospholipid Ether (PLE) Analogs As Cancer-Targeting Drug Vehicles
By GlobeNewswire
Jun 11, 2020 8:30 AM EDT
PRESS RELEASES
Cellectar Biosciences Announces Closing Of $20 Million Underwritten Public Offering
By GlobeNewswire
Jun 5, 2020 4:01 PM EDT
PRESS RELEASES
Cellectar Biosciences Announces Pricing Of $20 Million Underwritten Public Offering
By GlobeNewswire
Jun 3, 2020 9:00 AM EDT
PRESS RELEASES
Cellectar Receives FDA Fast Track Designation For CLR 131 In Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia
By GlobeNewswire
May 26, 2020 7:45 AM EDT
PRESS RELEASES
Cellectar Granted Composition Of Matter And Use Patent In Europe For CLR 131
By GlobeNewswire
May 14, 2020 8:00 AM EDT
MARKETS
3 Stocks Boosting The Health Care Sector Higher
By TheStreet Wire
Aug 21, 2015 4:34 PM EDT
MARKETS
3 Stocks Driving The Drugs Industry Higher
By TheStreet Wire
Aug 21, 2015 4:33 PM EDT
MARKETS
3 Stocks Pushing The Drugs Industry Lower
By TheStreet Wire
Aug 11, 2015 4:34 PM EDT
MARKETS
3 Stocks Driving The Drugs Industry Higher
By TheStreet Wire
Jul 30, 2015 4:33 PM EDT
MARKETS
3 Stocks Pushing The Drugs Industry Lower
By TheStreet Wire
Mar 9, 2015 4:34 PM EDT
MARKETS
3 Stocks Pushing The Drugs Industry Lower
By TheStreet Wire
Mar 5, 2015 3:35 PM EST
MARKETS
3 Stocks Pushing The Drugs Industry Lower
By TheStreet Wire
Feb 9, 2015 4:32 PM EST
MARKETS
3 Stocks Pushing The Drugs Industry Lower
By TheStreet Wire
Jan 30, 2015 4:32 PM EST
